Re: 'Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe' by Lange et al

Auteurs

Friesen, Inna; Francesca Saluzzo; Alexandra Aubry; Indra, Alexander; Vanessa Mathys; Yuliana Atanasovav; Mihaela Obrovac; Ljiljiana Žmak; Pieridou, Despo; Věra Dvořákov; Troels Lillebæk; Tiina Kummik; Kadri Klaos; Hanna Soini; Marjo Haanperä-Heikkinen; Silja Mentula; Jérôme, Robert; Emmanuelle Cambau; Stefan Niemann; Panayotis, Ioannidis; Dimitrios Papaventsis; Ágnes Bakos; Viktória Szél; Lilla Katalin Lőrinczi; Margaret Fitzgibbon; Breida Boyle; Daniela Maria Cirillo; Federico Giannoni; Ilva Pole; Inga Norvaiša; Laima Vasiliauskaite; Monique Perrin; Deguara, Catriona; Anthony, Richard; Anne Torunn Mengshoel; Ewa Augustynowicz-Kopeć; Rita Macedo; Roxana Mihaela Coriu; Igor Porvaznik; Špela Klemen; Laura Herrera-León; Ramona Groenheit; Jim Werngren